| Literature DB >> 35740457 |
Natalia Zeber-Lubecka1,2, Maria Kulecka1,2, Katarzyna Załęska-Oracka3, Michalina Dąbrowska2, Aneta Bałabas2, Ewa E Hennig1,2, Magdalena Szymanek-Szwed3, Michał Mikula2, Beata Jurkiewicz3, Jerzy Ostrowski1,2.
Abstract
The aim of this study is to determine the molecular differences between the urothelial transcriptomes of the bladder body and trigone. The transcriptomes of the bladder body and trigonal epithelia were analyzed by massive sequencing of total epithelial RNA. The profiles of urothelial and urinal microbiomes were assessed by amplicon sequencing of bacterial 16S rRNA genes in 17 adolescent females with pain and micturition dysfunction and control female subjects. The RNA sequencing identified 10,261 differentially expressed genes (DEGs) in the urothelia of the bladder body and trigone, with the top 1000 DEGs at these locations annotated to 36 and 77 of the Reactome-related pathways in the bladder body and trigone, respectively. These pathways represented 11 categories enriched in the bladder body urothelium, including extracellular matrix organization, the neuronal system, and 15 categories enriched in the trigonal epithelium, including RHO GTPase effectors, cornified envelope formation, and neutrophil degranulation. Five bacterial taxa in urine differed significantly in patients and healthy adolescent controls. The evaluation of their transcriptomes indicated that the bladder body and trigonal urothelia were functionally different tissues. The molecular differences between the body and trigonal urothelia responsible for clinical symptoms in adolescents with bladder pain syndrome/interstitial cystitis remain unclear.Entities:
Keywords: bladder body urothelium; microbiome; micturition dysfunction; trigonal urothelium
Year: 2022 PMID: 35740457 PMCID: PMC9220714 DOI: 10.3390/biomedicines10061435
Source DB: PubMed Journal: Biomedicines ISSN: 2227-9059
Results of urodynamic studies and histopathological findings in biopsy specimens of the trigonal urothelium taken from 17 adolescent girls with urological symptoms.
| Sample ID | Age (Years) | Results of Urodynamic Studies | Results of Histopathological Examination |
|---|---|---|---|
| 1B | 12 | Increased sensation in the bladder. High maximal pressure in the bladder during micturition. | Reactive changes in the urothelial epithelium and underlying florid proliferation of von Brunn’s nests |
| 2B | 17 | Not tested | Segmental non-keratinized squamous metaplasia without inflammatory infiltrates |
| 3B | 14 | Mild detrusor overactivity with increased sensation in the bladder | Slight chronic inactive inflammation of the urothelial epithelium with reactive changes and focal squamous non-keratinized metaplasia |
| 4B | 13 | Normal | Moderate chronic active inflammation and swelling of the urothelial epithelium with reactive changes |
| 5B | 17 | Increased sensation in the bladder with reduced bladder capacity. Lower urinary tract dysfunction with urgency sensors. | Focal chronic active inflammation of the urothelial epithelium with reactive changes of the urothelial epithelium and focal non-keratinized squamous metaplasia |
| 6B | 14 | Increased sensation in the bladder with reduced bladder capacity. | Moderate chronic active inflammation of the urothelial epithelium and non-keratinized squamous metaplasia |
| 7B | 17 | Increased sensation in the bladder with reduced bladder capacity. | Chronic inactive inflammation of the urothelial epithelium and visible non-keratinized squamous metaplasia |
| 8B | 18 | Detrusor overactivity with increased sensation in the bladder. Reduced bladder capacity. | Non-keratinized squamous metaplasia * |
| 9B | 17 | Urethral flow with bladder obstruction features. | Non-keratinized squamous metaplasia |
| 10B | 13 | Urethral flow with bladder obstruction features. | Reactive changes of the urothelial epithelium and underlying florid proliferation of von Brunn’s nests |
| 11B | 16 | Detrusor overactivity with increased sensation in the bladder. Reduced bladder capacity. | Normotypic urothelial epithelium with swelling of the stroma and sparse infiltrates of lymphoid cells |
| 12B | 14 | Detrusor overactivity with increased sensation in the bladder. Decreased bladder capacity. | Normotypic urothelial epithelium with swollen and bloodshot stroma |
| 13B | 16 | Detrusor overactivity with increased sensation in the bladder. Reduced bladder capacity. | Non-keratinizing squamous metaplasia |
| 14B | 17 | Detrusor overactivity with increased sensation in the bladder. Reduced bladder capacity. | Non-keratinized squamous metaplasia with poor lymphocyte infiltrates |
| 15B | 13 | Detrusor overactivity with increased sensation in the bladder. Reduced bladder capacity. | Non-keratinized squamous metaplasia and cystitis glandularis |
| 16B | 14 | Detrusor overactivity with increased sensation in the bladder. | Focal active inflammation of the urothelial epithelium and focal non-keratinized squamous metaplasia |
| 17B | 17 | Detrusor overactivity with increased sensation in the bladder | Focal chronic inactive inflammation of the urothelial epithelium and squamous non-keratinized metaplasia |
* An example of non-keratinized squamous metaplasia found at the triangle of the bladder (Figure 1).
Figure 1Histopathology examination showing non-keratinizing stratified squamous epithelium.
Figure 2(A). Numbers of common and unique genes with noticeable levels of expression (greater than ten reads) in at least three urothelial samples. (B). Principal component analysis (PCA) based on transcriptomic profiling, showing clustering of the samples according to the origin of the urothelium, with B and K indicating trigonal and body urothelium samples, respectively.
Figure 3Summary of the Reactome categories and functional pathways enriched in bladder body urothelium (shown in Table S3). Big dots—category; small dots—pathways.
Figure 4Summary of the Reactome categories and functional pathways enriched in trigonal urothelium (shown in Table S4). Big dots—category; small dots—pathways.
Figure 5Heatmap of the expression of keratins in bladder body and urothelium samples. The expression of each gene was log-normalized for visualization using DESEQ2 function rld and scaled with an R function scale.
Relative levels of expression of individual genes selected from the transcriptome data previously reported as being specifically expressed in human urothelium [7,18].
| Upregulated in Trigonal Urothelium | Upregulated in Body Urothelium | ||||
|---|---|---|---|---|---|
| Gene | FC | Gene | FC | ||
| CXCL1 | 1.57 × 10−49 | 386.85 | TAC1 | 5.49 × 10−17 | 47.38 |
| CXCL6 | 1.67 × 10−63 | 70.71 | CCL15 | 1.15 × 10−33 | 16.37 |
| CXCL3 | 1.00 × 10−15 | 34.22 | TH | 3.75 × 10−08 | 6.80 |
| CXCL2 | 1.02 × 10−15 | 28.83 | P2RX2 | 3.24 × 10−02 | 5.48 |
| CXCR1 | 4.20 × 10−05 | 9.46 | TRPV3 | 1.86 × 10−12 | 5.43 |
| CALCA | 1.93 × 10−02 | 8.08 | TRPA1 | 1.82 × 10−11 | 5.22 |
| CXCL17 | 1.69 × 10−25 | 7.51 | VIPR1 | 1.40 × 10−15 | 4.99 |
| CCL22 | 1.92 × 10−11 | 6.33 | CCL13 | 3.21 × 10−04 | 4.39 |
| CCL17 | 2.95 × 10−14 | 6.05 | CCL25 | 1.05 × 10−02 | 4.30 |
| CXCR2 | 4.18 × 10−27 | 5.77 | CCL16 | 4.54 × 10−02 | 3.96 |
| CCL7 | 1.12 × 10−02 | 5.12 | CCL27 | 8.98 × 10−04 | 3.71 |
| P2RY2 | 2.57 × 10−17 | 3.76 | CCL14 | 1.10 × 10−03 | 3.69 |
| TRPM6 | 7.46 × 10−04 | 2.95 | CHRM4 | 8.34 × 10−05 | 3.58 |
| CCL2 | 8.29 × 10−06 | 2.89 | P2RX6 | 3.51 × 10−05 | 3.40 |
| P2RY1 | 4.45 × 10−06 | 2.52 | CXCL12 | 4.10 × 10−07 | 3.20 |
| CXCL10 | 1.07 × 10−02 | 1.95 | CCL18 | 4.73 × 10−02 | 2.63 |
| CXCL16 | 4.22 × 10−04 | 1.74 | P2RX4 | 4.08 × 10−15 | 2.59 |
| CX3CL1 | 7.44 × 10−03 | 1.61 | CXCR2P1 | 1.26 × 10−02 | 2.41 |
| CXCR7 | 2.31 × 10−05 | 2.36 | |||
| P2RY4 | 1.01 × 10−02 | 2.27 | |||
| P2RX1 | 1.80 × 10−02 | 2.18 | |||
| P2RX5 | 3.50 × 10−02 | 2.15 | |||
| P2RY8 | 1.84 × 10−02 | 2.03 | |||
| TRPV2 | 8.50 × 10−04 | 1.81 | |||
| CXCR4 | 3.51 × 10-02 | 1.50 | |||
| TRPM7 | 5.16 × 10−05 | 1.40 | |||
| P2RX7 | 3.80 × 10−02 | 1.40 | |||
| TRPM4 | 4.04 × 10−02 | 1.38 | |||
FC; Fold Change.
Figure 6Genera of microbiomes isolated from bladder body (K) and trigonal (B) urothelium. Only the most abundant bacteria are shown.
Presence/absence and abundance differences of bacteria, as determined by Fisher’s exact test and metagenomeSeq.
| No. of Control Samples | No. of Patient Samples | FisherP | FisherAdjP | logFC | se | Size | Taxonomic Classification | ||
|---|---|---|---|---|---|---|---|---|---|
| 0 | 11 | 1.83 × 10−08 | 1.66 × 10−05 | 3.81 | 0.40 | 0.00 | 0.00 | 60,407 |
|
| 12 | 10 | 1.99 × 10−01 | 1.00 × 1000 | 3.92 | 0.66 | 2.12 × 10−09 | 9.59 × 10−07 | 51,881 |
|
| 0 | 7 | 1.62 × 10−04 | 2.45 × 10−02 | 1.29 | 0.29 | 5.94 × 10−06 | 1.79 × 10−03 | 2783 |
|
| 13 | 4 | 1.32 × 10−01 | 1.00 × 1000 | −4.52 | 1.05 | 1.85 × 10−05 | 4.19 × 10−03 | 855 |
|
| 16 | 1 | 9.04 × 10−05 | 2.45 × 10−02 | −1.53 | 0.39 | 9.09 × 10−05 | 1.65 × 10−02 | 1440 |
|
| 15 | 0 | 5.00 × 10−05 | 2.27 × 10−02 | −1.82 | 0.53 | 5.58 × 10−04 | 7.22 × 10−02 | 22,283 |
|
| 13 | 0 | 3.17 × 10−04 | 3.60 × 10−02 | −1.53 | 0.44 | 5.27 × 10−04 | 7.22 × 10−02 | 1344 |
|
| 13 | 0 | 3.17 × 10−04 | 3.60 × 10−02 | −1.44 | 0.42 | 6.66 × 10−04 | 7.53 × 10−02 | 1520 |
|
| 19 | 4 | 1.62 × 10−04 | 2.45 × 10−02 | −0.45 | 443,343 |
| |||
| 19 | 4 | 1.62 × 10−04 | 2.45 × 10−02 | −2.99 | 8891 |
|
FisherP, FisherAdjP—p-value and adjusted p-value in Fisher’s exact test for presence/absence of taxa in samples; logFC—logarithm with base 2 from fold-change; p-value, padj-value—p-value for differential bacterial abundance testing in metagenomeSeq model; Size—total number of reads.